Is epclusa for hep c?

Is Epclusa (sofosbuvir/velpatasvir) for hepatitis C?

Yes. Epclusa is a prescription medicine used to treat chronic hepatitis C virus (HCV) infection. It combines two direct-acting antivirals—sofosbuvir and velpatasvir—that work against the hepatitis C virus to clear the infection in eligible patients. [1]

What kinds of hepatitis C does Epclusa cover?

Epclusa is used for adults with chronic HCV infection across multiple genotypes, and it’s also used in certain pediatric patients depending on weight/age and treatment criteria set by clinicians and prescribing information. [1]

How is Epclusa usually taken, and how long is treatment?

For many patients, Epclusa is taken as a once-daily tablet regimen for a fixed course length determined by factors such as prior treatment history and whether the patient has cirrhosis (and its severity). [1]

What should people ask their clinician before starting Epclusa?

Patients typically need medication review and safety checks because hepatitis C regimens can interact with other drugs, and certain liver conditions can affect treatment planning. It’s also important to confirm the HCV type and the presence of cirrhosis before finalizing the course length. [1]

Is Epclusa used for hepatitis B or HIV?

Epclusa is specifically for hepatitis C. It is not used to treat hepatitis B, and it’s not an HIV regimen. Patients with co-infections may still need specialist guidance because of monitoring and interactions with other therapies. [1]

Sources
[1] https://www.drugs.com/epclusa.html